Study reveals prostate cancer risk increased in obese men

According to findings of a new study at the Fred Hutchinson Cancer Research Center in Seattle, use of cholesterol-lowering statin drugs, especially long-term use, appears to raise the risk of prostate cancer among obese men. No overall association was found between the risk of prostate cancer and the current or past use of statin treatment. Duration of statin use was also not associated with prostate cancer risk.
[ continue reading ]